Brief shocks may deliver AIDS vaccines better

by Mary J. Lewis on October 27, 2009

Sandy_vasan

Sandhya Vasan

Brief electric shocks may help the body better respond to certain kinds of experimental AIDS vaccines, U.S. researchers said Oct. 22.

Grants given for unconventional projects to fight infectious diseases

by Mary J. Lewis on October 27, 2009

Tachi_yamada

Dr. Tachi Yamada

ARUSHA, Tanzania — The Bill & Melinda Gates Foundation announced 76 grants of $100,000 each to pursue bold ideas for transforming health in developing countries.

H1N1 vaccine ‘remarkably safe,’ NIH director says

by Daniel Purt on October 19, 2009

Collins_directorpage

Dr. Francis Collins

CHICAGO — There is nothing unique or scary about the new H1N1 flu vaccine that should keep people from getting it, said Dr. Francis Collins, director of the U.S. National Institutes of Health.

NIH Launches H1N1 flu vaccine trial in HIV-infected pregnant women

by Mary J. Lewis on October 18, 2009

Faucismilelabsmall

Anthony S. Fauci

The first clinical trials to test whether the 2009 H1N1 influenza vaccine can safely elicit a protective immune response in HIV-infect

UTEP focuses on TB vaccine research

by Daniel Purt on October 6, 2009

With all the attention on H1N1 and the seasonal flu, it might be easy to forget about other infectious diseases.

Tuberculosis consortium, Vivalis to explore production capabilities

by Rita Uplend on October 2, 2009

The Oxford-Emergent Tuberculosis Consortium Ltd. has signed an agreement with Vivalis to evaluate large-scale commercial production capabilities for MVA85A, the consortium’s new TB vaccine candidate.

Novavax researching vaccine for common respiratory virus

by Pat Dulnier on September 27, 2009

ROCKVILLE, Md. — Novavax has received a grant to support preclinical research of a vaccine for the most commonly identified cause of lower respiratory illnesses in infants and young children.

AIDS vaccine expert encouraged by promising results

by Mary J. Lewis on September 27, 2009

When promising results from a large clinical trial of an AIDS vaccine regimen were announced recently, it was good news to the inventor of one of the vaccines used in the trial.

Virginia Tech wins $27 million contract for infectious disease research

by Daniel Purt on September 25, 2009

BLACKSBURG, Va. — Virginia Tech will use $27 million to support infectious disease research around the world.

Cholera vaccine seen safe, effective in India study

by Ted Purlain on September 20, 2009

A cholera vaccine has proved to be safe and effective in young children in a part of India where the disease is endemic, a new study in The Lancet says.